Retrospektive Untersuchung der Anti-VEGF-Behandlungsrealität und Wirksamkeit bei Patienten mit neovaskulärer altersabhängiger Makuladegeneration (nAMD) in Deutschland-Reference-Cited by-同舟云学术

Retrospektive Untersuchung der Anti-VEGF-Behandlungsrealität und Wirksamkeit bei Patienten mit neovaskulärer altersabhängiger Makuladegeneration (nAMD) in Deutschland

Published:2015-02-12 Issue:3 Volume:112 Page:246-254
ISSN:0941-293X
Container-title:Der Ophthalmologe
language:de
Short-container-title:Ophthalmologe

Author:

Ziemssen F., ,Eter N.,Fauser S.,Bopp S.,Radermacher M.,Hasanbasic Z.,Holz F.G.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00347-014-3217-7.pdf

Reference18 articles.

1. Augood CA, Vingerling JR, De Jong PT et al (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124:529–535

2. Brown DM, Michels M, Kaiser PK et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65

3. Chakravarthy U, Harding SP, Rogers CA et al (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 382:1258–1267

4. Cohen SY, Mimoun G, Oubraham H et al (2013) Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study. Retina 33:474–481

5. Finger RP, Wiedemann P, Blumhagen F et al (2013) Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study – a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol 91:540–546

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization;Scientific Reports;2023-09-28

2. Results of anti-VEGF treatment for neovascular AMD in eyes with different baseline visual acuity in Turkish population-based on real life data-Bosphorus retina study group;Photodiagnosis and Photodynamic Therapy;2023-06

3. Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre study;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-03-16

4. Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting;International Ophthalmology;2022-07-04

5. Creation of a neovascular age‐related macular degeneration national database using a web‐based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes;Clinical & Experimental Ophthalmology;2022-02-20